ICD-10 code D75.0: Familial erythrocytosis billing and coding guide

Key Takeaways

ICD-10 code D75.0 is a billable ICD-10-CM diagnosis code for familial erythrocytosis, valid for fiscal year 2026

Inclusion terms cover benign familial polycythemia, Chuvash erythrocytosis, and familial polycythemia

D75.0 must not be confused with D45 (Polycythemia vera) or D75.1 (Secondary polycythemia) – clinical documentation must distinguish hereditary cause

Pabau’s claims management software supports accurate code capture and claim submission workflows for hematology practices

ICD-10 code D75.0 captures familial erythrocytosis – a genetically driven elevation of red blood cell mass – but coders frequently misassign it to polycythemia vera (D45) or secondary polycythemia (D75.1) because the clinical presentations overlap. Getting the distinction right starts with the documentation, not the lookup tool.

This reference guide covers the clinical definition, inclusion terms, excludes notes, related codes, and documentation requirements for ICD-10 code D75.0 – everything hematologists, primary care physicians, and medical coders need to assign and bill the code accurately.

ICD-10 code D75.0: Definition and clinical description

Familial erythrocytosis is a hereditary condition characterized by an abnormally elevated red blood cell mass resulting from a genetic defect, such as a mutation in the VHL gene that alters erythropoietin sensitivity. Unlike polycythemia vera, which is an acquired myeloproliferative neoplasm, familial erythrocytosis is inherited and typically presents in multiple family members across generations.

The CMS ICD-10-CM code set classifies ICD-10 code D75.0 within Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89). Specifically, it falls under the subcategory D70-D77: Other disorders of blood and blood-forming organs.

The parent code D75 covers other and unspecified diseases of blood and blood-forming organs, and D75.0 is the first and most specific billable code in that range.

Clinicians should document the hereditary nature of the elevated erythrocyte count explicitly. Phrases like “familial” or “hereditary” in the diagnostic note are what justify D75.0 over D75.1 during a payer review. For functional medicine software users managing complex hematology presentations alongside metabolic workups, accurate code selection at the point of documentation avoids rework downstream.

Inclusion terms and synonyms for ICD-10 code D75.0

Several clinical terms map to D75.0 in the ICD-10-CM tabular list. Coders encountering any of these in physician documentation should consider D75.0 as the appropriate code – provided no specific excludes notes apply.

• Benign familial polycythemia – hereditary polycythemia not associated with a myeloproliferative neoplasm
• Familial polycythemia – general term for inherited red cell mass elevation
• Chuvash erythrocytosis – a specific autosomal recessive form linked to VHL gene mutation (c.598C>T), originally described in the Chuvash population of Russia but identified globally

When physician notes use “Chuvash polycythemia,” “hereditary erythrocytosis,” or “congenital erythrocytosis,” these phrases are clinically consistent with D75.0. Coders should query the provider if documentation is ambiguous between a familial cause and an acquired one such as polycythemia vera (D45). Building the query step into the EHR workflow reduces the back-and-forth that delays claim submission.

Excludes notes and related codes

D75.0 carries important excludes notes that define its boundaries. Misreading these is one of the most common sources of incorrect code assignment in hematology billing.

Codes excluded from D75.0

The following conditions are specifically excluded from D75.0 – they must be coded elsewhere even when the presentation involves elevated red blood cell mass:

• Polycythemia vera (D45) – an acquired myeloproliferative neoplasm. D45 and D75.0 are mutually exclusive: if a patient’s polycythemia is confirmed as a JAK2-mutation-driven neoplasm, D45 applies, not D75.0.
• Secondary polycythemia (D75.1) – covers acquired erythrocytosis from identifiable causes such as high altitude, chronic hypoxia, renal disease, or erythropoietin-secreting tumors. High-altitude polycythemia is D75.1, not D75.0.
• Polycythemia neonatorum (P61.1) – neonatal polycythemia coded under perinatal conditions.

Reviewing the D75 parent category and its siblings (D45, D75.1) before finalizing the code is good practice for any coder handling hematology claims. Linking to related blood disorder codes in your EHR’s reference library speeds up this cross-check.

D75.0 vs. D45 vs. D75.1: Choosing the right code

The critical coding distinction: D75.0 requires evidence of hereditary cause. If the chart shows only elevated hematocrit without genetic context or family history, the documentation is insufficient to support D75.0. A coder should either query the provider or hold the claim pending clarification.

Coding guidelines and documentation requirements for ICD-10 code D75.0

Most claim denials for D75.0 trace back to one problem: documentation that describes the elevated red cell mass without specifying its cause. The ICD-10-CM Official Guidelines for Coding and Reporting, maintained by CMS and NCHS, require that coders assign the most specific code supported by the medical record. “Polycythemia, unspecified” is not an acceptable substitute when hereditary cause is clinically established.

What the medical record must contain

• Explicit diagnosis statement: The provider must document “familial erythrocytosis,” “hereditary erythrocytosis,” “benign familial polycythemia,” or equivalent language. Elevated hematocrit alone does not justify D75.0.
• Etiology context: A note referencing family history of erythrocytosis, genetic testing results (e.g., VHL mutation), or prior established diagnosis in a family member strengthens specificity.
• Exclusion of acquired causes: Documentation should note that secondary causes (hypoxia, renal pathology, exogenous erythropoietin) have been ruled out, distinguishing the case from D75.1.
• Distinction from polycythemia vera: If JAK2 testing was performed, the result should be in the chart. A negative JAK2 result supports D75.0 over D45.

Storing these documentation elements in a structured patient record management system – rather than buried in free-text notes – makes them retrievable at audit without delay. Practices using digital intake forms can capture hereditary history at the point of patient onboarding, which flows directly into the clinical note template.

Principal vs. additional diagnosis sequencing

When familial erythrocytosis is the reason for the encounter (e.g., a hematology visit to manage erythrocytosis), D75.0 is the principal diagnosis. When it is an incidental finding or a comorbidity managed alongside another primary condition, it becomes an additional diagnosis coded after the principal code.

Correct sequencing affects MS-DRG grouping for inpatient claims and influences reimbursement under prospective payment models.

Building standard operating procedures around sequencing decisions – particularly for chronic conditions that appear across multiple encounters – reduces coder variability and supports consistent claim outcomes. The same discipline applies when coding related anemia diagnoses that may accompany a hematology workup.

MS-DRG groupings and payer considerations

ICD-10 code D75.0 groups into MS-DRGs related to red blood cell disorders for inpatient hospital claims. The specific MS-DRG assignment depends on the presence of a major complication or comorbidity (MCC) or complication or comorbidity (CC).

Coders handling inpatient hematology encounters should identify any qualifying MCCs or CCs documented in the record to optimize appropriate DRG assignment.

For outpatient claims, D75.0 is assigned without DRG grouping. Instead, it supports medical necessity for services billed under associated procedure codes – such as complete blood count (CBC) panels, which also screen for coexisting conditions like iron deficiency anemia, genetic testing, and hematology consultations. Payers typically expect D75.0 to appear alongside relevant procedure codes that are clinically consistent with managing a hereditary blood disorder.

The CDC/NCHS ICD-10-CM web tool allows coders to verify current-year code validity, applicable includes/excludes, and instructional notes before claim submission. Verifying D75.0 against the 2026 edition confirms the code remains active and unchanged from prior fiscal years.

Reduce coding errors with smarter claim workflows

Pabau's claims management software helps hematology and primary care practices capture accurate diagnosis codes, track claim status, and resolve denials faster – all from one platform.

Book a demo

ICD-10 code D75.0 crosswalk and code history

D75.0 maps directly from ICD-9-CM code 289.6 (Familial polycythemia). The transition from ICD-9 to ICD-10 in October 2015 maintained a clean one-to-one crosswalk for this condition.

No code logic changes have been applied to D75.0 since the initial ICD-10-CM implementation, and the 2026 fiscal year edition confirms the code remains valid and billable without revision.

ICD-9 to ICD-10 crosswalk

Practices still referencing older superbills or fee schedule templates may still carry the ICD-9 code 289.6. Any claim submitted with ICD-9 codes to a payer requiring ICD-10-CM will be rejected outright. Updating the primary care EHR documentation templates to use D75.0 is the simplest fix for this category of rejection.

Billing workflow for D75.0 claims

Accurate coding is only the first step. A claim for familial erythrocytosis also needs supporting documentation and correct procedural code pairing to pass payer edits. Here is a practical workflow for practices managing D75.0 encounters.

1. Capture the hereditary diagnosis at intake. Flag patients with a known family history of erythrocytosis in the problem list. This seeds the diagnosis code into every subsequent encounter note without requiring the provider to re-establish it from scratch.
2. Confirm supporting lab results are in the chart. A CBC showing elevated hematocrit or hemoglobin, alongside any genetic panel results, substantiates medical necessity for the office visit and any associated testing.
3. Select D75.0 and sequence correctly. For encounters where erythrocytosis management is the stated reason for the visit, D75.0 goes first. Add any relevant comorbidities (e.g., hypertension, thrombotic events) as secondary codes.
4. Pair with appropriate procedure codes. Common CPT codes accompanying D75.0 include 85025 (CBC with differential), 82668 (Erythropoietin level), and 99213-99215 (Evaluation and management, level of complexity).
5. Submit and track denial patterns. Use a claims management software system to monitor D75.0 claim outcomes. A pattern of denials citing “diagnosis not medically necessary” signals that documentation is not translating correctly into the claim.

Practices handling hematology billing alongside other specialties benefit from software that connects the clinical note directly to the claim. Using HIPAA-compliant practice software with integrated billing workflows reduces the manual handoff between the clinical team and the billing team – the point where D75.0 is most likely to get miscoded or dropped.

The AAPC Codify ICD-10-CM lookup provides additional crosswalk references and payer policy notes for D75.0 that can supplement your internal billing guidelines. For direct primary care practice software users who manage hematology as part of a broad panel, building D75.0 into a standard chronic condition management protocol prevents it from being overlooked on routine visits.

Conclusion

Familial erythrocytosis claims fail when documentation stops at “elevated hematocrit” and does not connect the finding to its hereditary cause. ICD-10 code D75.0 is straightforward to assign correctly – but only when the provider note explicitly records the genetic or familial basis and the coder has a reliable workflow to verify documentation before submission.

Pabau’s claims management software gives hematology and primary care practices the tools to catch these documentation weaknesses before a claim leaves the practice – connecting clinical documentation, code assignment, and denial tracking in one system. To see how it works for your billing team, book a demo.

Continue your research

Need a structured approach to hematology documentation? Practice management software explains how integrated billing and documentation tools reduce coding errors across specialties.

Managing complex chronic conditions in primary care? Patient care management covers how to build condition-specific protocols that support accurate ongoing coding.

Concerned about HIPAA documentation standards? Paperless practice and HIPAA compliance walks through digital record-keeping requirements for outpatient billing workflows.

Frequently Asked Questions